What is it about?
"Efficacy of the anti-VZV (anti-HHV-3) vaccine against HSV1 and HSV2 recurrent Herpes simplex disease" suggests the ability to enhance Varicella Virus immune genetic power. Then, the Varicella Vaccine appears able to enhance immunological defense against recurrent Herpes diseases.
Featured Image
Read the Original
This page is a summary of: Efficacy of the anti-VZV (anti-HSV3) vaccine in HSV1 and HSV2 recurrent herpes simplex disease: a prospective study, Open Access Journal of Clinical Trials, July 2012, Dove Medical Press,
DOI: 10.2147/oajct.s33292.
You can read the full text:
Contributors
The following have contributed to this page
